These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 19514518)
1. [Mitoxantrone for the treatment of patients with multiple sclerosis]. Komori M; Kondo T; Tanaka M Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518 [TBL] [Abstract][Full Text] [Related]
2. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
3. Rationale for the use of mitoxantrone in multiple sclerosis. Edan G; Morrissey S; Le Page E J Neurol Sci; 2004 Aug; 223(1):35-9. PubMed ID: 15261558 [TBL] [Abstract][Full Text] [Related]
11. Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis. Zecca C; Petrini L; Limoni C; Staedler C; Gobbi C Eur Neurol; 2011; 65(1):40-5. PubMed ID: 21196739 [TBL] [Abstract][Full Text] [Related]
12. The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis. Jeffery DR J Neurol Sci; 2004 Aug; 223(1):41-6. PubMed ID: 15261559 [TBL] [Abstract][Full Text] [Related]
13. [Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis]. Saida T Rinsho Shinkeigaku; 2004 Nov; 44(11):796-8. PubMed ID: 15651294 [TBL] [Abstract][Full Text] [Related]